The Ophthalmology Innovation Summit
NOVEMBER 22-23 | SAN DIEGO, CA - HARD ROCK HOTEL
Connecting clinical, corporate, and capital leaders to drive the ophthalmic market forward. This two-day event will showcase groundbreaking advancements and clinical insights in both anterior and posterior ophthalmology segments and promises unmatched learning, networking, and collaboration.
OIS XIV ONSITE
The Ophthalmology Innovation Summit
NOVEMBER 22-23 | SAN DIEGO, CA - HARD ROCK HOTEL
ADVISORY BOARD
Sharon Bakalash, MD, PhD
Paul Bresge
Emmett T. Cunningham Jr., MD, PhD, MPH
Pravin U. Dugel, MD
Daniela Ferrara, MD, MS, PhD, FASRS
Firas Rahhal, MD
Rob Rothman, MD
Anthony Wallace
Susan Benton
The OIS meeting is one of the most relevant and best forums for bringing together all stakeholders involved in ophthalmic innovation. The program delivers quality content from a diverse group of experts across both the pharmaceutical and med device spaces. This is a must attend program for anyone who is developing tomorrow's innovation today.
Veysel Ozkapici
Participating in OIS XIV was an exceptional experience for GlaucoT. The conference provided a unique platform to showcase our innovative solutions for glaucoma management, including our groundbreaking wearable neuroprotective system and the novel mobile camera-based intraocular pressure measurement technology. Engaging with leading experts, investors, and strategic partners in the ophthalmology space was invaluable. The insightful discussions and feedback we received have further fueled our mission to revolutionize glaucoma treatment. We are grateful for the opportunity to connect with such a vibrant and forward-thinking community and look forward to continuing our journey with the momentum gained from OIS XIV.
David Killengray
OIS represents a great opportunity to see the coming developments in ophthalmology, delivered by innovators. There is a real opportunity to learn about the issues affecting startups and the process of getting an idea realized into a product and beyond.
Sanjeev Ganatra
OIS continues to be true to its name as the Ophthalmic Innovation Source. A source for early companies to have a friendly and welcoming on ramp into eye care and a source for investors and strategic companies to be introduced to and evaluate the next generation of innovators and innovations.
James Murray
OIS continues to be a must attend event for anyone in the ophthalmology space. The organizers curate an ever-evolving slate of discussions that reflect the market and set the tone for the next year.
Jeroen Wissink
This is networking to the max.